A novel combinatorial strategy using Seliciclib (R) and Belinostat (R) for eradication of non-small cell lung cancer via apoptosis induction and BID activation

• Main Authors: Ong, Pei-Shi, Wang, Lingzhi, Chia, Deborah Miao-Hui, Seah, Jolyn Yu-Xin, Kong, Li-Ren, Thuya, Win-Lwin, Chinnathambi, Arunachalam, Lau, Jie-Ying Amelia, Wong, Andrea Li-Ann, Yong, Wei-Peng, Yang, Daiwen, Ho, Paul Chi-Lui, Sethi, Gautam, Goh, Boon-Cher
• Other Authors: BIOLOGY (NU)
• Format: Article
• Language: English
• Published: ELSEVIER IRELAND LTD 2020
• Subjects: Science & Technology; Life Sciences & Biomedicine; Oncology; Belinostat (R); Seliciclib (R); Non-small cell lung cancer; Caspase-8 activation; Truncated BID; HISTONE DEACETYLASE INHIBITORS; DEPENDENT KINASE INHIBITOR; DEATH; P53; FLAVOPIRIDOL; ENHANCEMENT; CARBOPLATIN; ROSCOVITINE; EXPRESSION; PACLITAXEL
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/175510
• Institution: National University of Singapore

10.1016/j.canlet.2016.07.023